A new study suggests an RNA-based therapy could help semaglutide target more fat while reducing the lean-muscle loss associated with GLP-1 weight loss.

Source: [Inc.](https://www.inc.com/jelinda-montes/this-experimental-treatment-could-make-wegovy-and-ozempic-even-more-effective/91412996)

Sponsored